EC Number   |
|---|
    4.2.1.1 | - |
| 4.2.1.1 | 2 different tetragonal crystal forms, form 1 space group P4(2)2(1)2, unit cell dimensions a : b : 68.54 A, c : 85.88A, form 2 space group P4(3)22, a : : b : 81.24 A, c : 162.14 A |
| 4.2.1.1 | all variants crystallized in the orthorhombic P2(1) 2(1) 2 (1) space group and are highly isomorphous with approximate unit cell dimensions a=42, b=72 and c=75 A and diffract between 1.56 and 2.0 A resolution |
| 4.2.1.1 | CA XII crystallized by the hanging drop vapor diffusion method, space group C2 with unit cell dimensions a : 146.7 A, b : 44.6 A, c : 85.2 A |
| 4.2.1.1 | Can2 in complex with acetate, hanging drop vapour diffusion method |
| 4.2.1.1 | carbonic anhydrase II complexed with two aromatic sulfonamide inhibitors N-(4-sulfamoylphenyl)-2-(thiophen-2-yl)acetamide and N-(2-fluoro-4-sulfamoylphenyl)-2-(thiophen-2-yl)acetamide incorporating 2-thienylacetamido moieties, hanging drop vapor diffusion method, drops of 0.005 ml containing 0.5 mM hCA II, 1 mM inhibitor, 0.1% DMSO, 0.8 M sodium citrate, 50 mM Tris-HCl, pH 8.0,are equilibrated against 1 ml precipitant solution containing 1.6 M sodium citrate and 50 mM Tris-HCl, pH 8.0, at room temperature, X-ray diffraction structure determination and analysis at 1.6-1.7 A resolution |
| 4.2.1.1 | carbonic anhydrase II inhibited by CN- or OCN- |
| 4.2.1.1 | carboxamidomethyl derivative |
| 4.2.1.1 | Cd2+-bound CDCA1 in the presence of acetate |
| 4.2.1.1 | complex with the inhibitor acetazolamide |
